| Company | Role | Class | Num Shares | Value | Price $ | Report Date | Ownership |
|---|---|---|---|---|---|---|---|
| Phathom Pharmaceuticals, Inc. | VP, Chief Accounting Officer | Common Stock | 8,399 | $68,032 | $8.10 | 19 Jan 2022 | Direct |
| Phathom Pharmaceuticals, Inc. | VP, Chief Accounting Officer | Common Stock | 464 | $3,755 | $8.10 | 19 Jan 2022 | by 401(k) |
| Phathom Pharmaceuticals, Inc. | VP, Chief Accounting Officer | Stock Option (Right to Buy) | 30,000 | 19 Jan 2022 | Direct |
| Symbol | Company | Period | Transactions | Value $ | Form Type | Role | Filing Time |
|---|---|---|---|---|---|---|---|
| PHAT | Phathom Pharmaceuticals, Inc. | 19 Jan 2022 | 2 | $0 | 4 | VP, Chief Accounting Officer | 21 Jan 2022, 17:49 |
| PHAT | Phathom Pharmaceuticals, Inc. | 04 Jun 2021 | 0 | $0 | 3 | VP, Chief Accounting Officer | 11 Jun 2021, 16:44 |